The absolute risk increase for diabetic retinopathy complications was larger among patients with a history of diabetic retinopathy at baseline (semaglutide injection 8.2%, placebo 5.2%) than among patients without a known history of diabetic retinopathy (semaglutide injection 0.7%, placebo 0.4%)
It is often used for: Subcutaneous injections (Delivered into fatty tissue beneath the skin) that require ongoing or repeated dosing , such as hormone therapies, peptides, insulin-adjacent treatments, or growth hormone preparations
As an internal and family medicine doctor, Karen Thampoe, MD, provides comprehensive health care for adult and geriatric patients at West Houston Internal Medicine in Katy, Texas and is the owner and Medical Director of Katy Medispa
These effects suggest potential applications in peripheral neuropathies and traumatic nerve injuries, though human efficacy data remains limited